720. Deputy Seán Kyne asked the Minister for Health the current status of the HSE's assessment of dupilumab for eosinophilic oesophagitis; and the expected date of a decision on the use of this medicine. [70680/26]
Parliamentary questions
Questions
TDs ask ministers questions to get answers on the record, most of them in writing. Here is every one asked in the 34th Dáil, by the department it went to and the subject heading it was filed under. How questions work
Browse the questions
Showing questions asked by Seán Kyne under the heading Medicinal Products.
5 questions match, newest first.
721. Deputy Seán Kyne asked the Minister for Health the action the HSE and HPRA are taking on the current supply shortage of budesonide orodispersible tablets in the State. [70677/26]
723. Deputy Seán Kyne asked the Minister for Health the current status of the HSE's full health technology assessment of budesonide orodispersible tablets (Jorveza, NCPE HTA ID 24014) for eosinophilic oesophagitis, commissioned on 25 June 2024; the reason no outcome has been published in over two years; and the expected date of a reimbursement decision. [70675/26]
1299. Deputy Seán Kyne asked the Minister for Health in regard to online prescriptions of weight loss medication, what happens when a patient deliberately provides inaccurate information or photographs of their current condition (details supplied); the minimum clinical assessment required before high-dose weight-loss medication is prescribed remotely; and if patients with very low body weight or a history of eating …
1300. Deputy Seán Kyne asked the Minister for Health if there is currently a system that allows prescribers of weight loss medication to identify whether a patient is receiving such medication from multiple prescribing providers; if an online private prescriber can see relevant prescription information issued by other providers; the identity-verification requirements that apply to online prescribing services; and the…